Management of overactive bladder in a difficult-to-treat patient with a transdermal formulation of oxybutynin.

Abstract

Antimuscarinic agents, effective in relieving symptoms of overactive bladder, are associated with anticholinergic-mediated adverse events, particularly at high dosages. The outcome of a difficult-to-treat patient requiring high doses of anticholinergic therapy who was successfully treated with transdermal oxybutynin after failing oral therapies is reported.

• Authors: Leslie Saltzstein
• Journal: Urologic nursing (Urol Nurs) Vol. 25 Issue 4 Pg. 260-2 (Aug 2005) ISSN: 1053-816X [Print] United States
• PMID: 16225342 (Publication Type: Case Reports, Journal Article)

Chemical References

• Mandelic Acids
• Muscarinic Antagonists
• oxybutynin

Topics

• Administration, Cutaneous
• Administration, Oral
• Aged, 80 and over
• Chemistry, Pharmaceutical
• Constipation (chemically induced)
• Exercise Therapy
• Female
• Humans
• Mandelic Acids (chemistry, pharmacology, therapeutic use)
• Muscarinic Antagonists (chemistry, pharmacology, therapeutic use)
• Pelvic Floor
• Self Care
• Toilet Training
• Treatment Outcome
• Urinary Incontinence (diagnosis, drug therapy, prevention & control)
• Urodynamics